Cost-effectiveness of introducing a maternal vaccine or long-acting monoclonal antibody to prevent infant respiratory syncytial virus disease in Nepal.
Saved in:
| Title: | Cost-effectiveness of introducing a maternal vaccine or long-acting monoclonal antibody to prevent infant respiratory syncytial virus disease in Nepal. |
|---|---|
| Authors: | Rave N; Department of Paediatrics, University Medical Centre Utrecht, Utrecht, the Netherlands., Sharma AK; Department of Paediatrics, Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.; Nepal Paediatric Society, Kathmandu, Nepal., Chapagain RH; Department of Paediatrics, Kanti Children's Hospital, Kathmandu, Nepal.; Nepal Paediatric Society, Kathmandu, Nepal., Nguyen A; PATH, Center for Vaccine Innovation and Access, Ho Chi Minh City, Vietnam., Pecenka C; PATH, Center for Vaccine Innovation and Access, Seattle, Washington, USA., Shaaban FL; Department of Paediatrics, University Medical Centre Utrecht, Utrecht, the Netherlands., Bont LJ; Department of Paediatrics, University Medical Centre Utrecht, Utrecht, the Netherlands., Clark A; Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK. |
| Corporate Authors: | RSV GOLD III – Health Economics Study Group |
| Source: | Journal of global health [J Glob Health] 2025 Nov 14; Vol. 15, pp. 04292. Date of Electronic Publication: 2025 Nov 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: International Society of Global Health Country of Publication: Scotland NLM ID: 101578780 Publication Model: Electronic Cited Medium: Internet ISSN: 2047-2986 (Electronic) Linking ISSN: 20472978 NLM ISO Abbreviation: J Glob Health Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
